The U.S. Securities and Exchange Commission said today that it halted trading in Anaheim-based Wholehealth Products Inc. and three other penny stock companies that “claim to be developing products and services in response to the Ebola [virus] outbreak.”
The SEC cited a “lack of publicly available information on the companies’ operations” as a reason to stop trading.
The agency also issued an investor alert about the potential for “fraud in microcap companies purportedly involved in Ebola prevention, testing or treatment.”
Wholehealth said Monday that it would file for Food and Drug Administration emergency approval of a blood test for detecting the Ebola virus.
Wholehealth’s shares had a market value of some $5 million before its stock was suspended.
